During the past decade, John B. Amos Cancer Center conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 119 clinical trials were completed, i.e. on average, 258.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 52 clinical trials were completed. i.e. 1040% of trials that started reached the finish line.

Out of the total clinical trials conducted in "John B. Amos Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 55 trials, followed by "Radiation Therapy Oncology Group" with 48 trials sponsored, "SWOG Cancer Research Network" with 34 trials sponsored, "Alliance for Clinical Trials in Oncology" with 24 trials sponsored and "Gynecologic Oncology Group" with 24 trials sponsored. Other sponsors include 39 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "John B. Amos Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 131 trials as a collaborator, "NRG Oncology" with 30 trials as a collaborator, "NCIC Clinical Trials Group" with 11 trials as a collaborator, "Cancer and Leukemia Group B" with 9 trials as a collaborator and "North Central Cancer Treatment Group" with 9 trials as a collaborator. Other collaborators include 53 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "John B. Amos Cancer Center" are "Breast Cancer" (21 trials), "Prostate Cancer" (16 trials), "Lung Cancer" (13 trials), "Colorectal Cancer" (9 trials) and "Head and Neck Cancer" (9 trials). Many other conditions were trialed in "John B. Amos Cancer Center" in a lesser frequency.

Most popular intervention types in "John B. Amos Cancer Center" are "Drug" (166 trials), "Other" (101 trials), "Biological" (67 trials), "Radiation" (65 trials) and "Procedure" (37 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (57 trials), "Quality-of-Life Assessment" (36 trials), "radiation therapy" (35 trials), "Paclitaxel" (23 trials) and "Bevacizumab" (17 trials). Other intervention names were less common.

The vast majority of trials in "John B. Amos Cancer Center" are 153 trials for "All" genders, 43 trials for "Female" genders and 16 trials for "Male" genders.

Currently, there are NaN active trials in "John B. Amos Cancer Center". undefined are not yet recruiting, 6 are recruiting, 66 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 123 completed trials in John B. Amos Cancer Center, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in John B. Amos Cancer Center, 12 "Phase 1" clinical trials were conducted, 73 "Phase 2" clinical trials and 125 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".